Half of Americans Will Be Diagnosed With Cancer by 2030
Published July 10, 2019 | Health, Inflammation
Cancer is an “abnormal growth of cells.” That is perhaps the most succinct description of the disease, which is really more a group of diseases
since there are more than 100 types of cancer. Cancer cells
are malignant—meaning that they can invade and spread to different parts of the body, forming solid tumors (masses of tissue) that can damage organs and tissue.1 2 3 4 5
The 13 most common forms of cancers in the United States are breast cancer, followed by lung, prostrate, colorectal, skin, bladder, lymphatic, kidney, uterine, blood, pancreatic, thyroid and liver cancers.6 In fact, cancer is the second leading cause of death in the U.S.7
A study by the American Cancer Society (ACS) published on Jan. 8, 2019 estimates there will be 1,762,450 new cases of cancer in the U.S. this year and 606,880 deaths caused by cancer, or nearly 1,700 deaths per day.8 9 The number of new cancer cases in the U.S. has been steadily increasing during the past decade. There were about 1.5 million cases in 2010, and the Centers for Disease Control and Prevention (CDC) projects the rate will reach 1.9 million by 2020.10
According to the National Cancer Institute (NCI), the number of new cancer cases of cancer in the U.S. is 439.2 per 100,000 men and women annually. About 38.4 percent of men and women in the U.S. will be diagnosed with cancer “at some point during their lifetimes.”11
The NCI estimates that the national expenditures for cancer care in the U.S. in 2017 were $147 billion, compared to $137.4 billion in 2010. It believes these costs are “likely to increase as the population ages and cancer prevalence increases.”11 12 In fact, it projects that U.S. expenditures for cancer care will reach $174 billion by 2020.13
The ACS estimates that new cancer cases in the U.S. will increase by as much as 50 percent by 2030. This means that, within the next decade, approximately 1 in 2 Americans are expected to be diagnosed with cancer.14 15
Because of this growing and alarming epidemic, there has been a kind of quest by the vaccine manufacturing industry to produce a “universal cancer vaccine” that would treat and help cure cancer by teaching the immune system to attack cancer cells. Even Google has joined the quest by investing millions of dollars in venture capital to help finance start-up biotech companies doing research on a cancer vaccine.16 17
There have been some breakthroughs in recent years on the development of an effective therapeutic cancer vaccine but, thus far, this “holy grail” of the vaccine industry remains elusive.18 19 20
Scientists maintain that human exposure to environmental toxins can cause damage to DNA that alters the way our cells function and leads to cancer.21
Ironically, one toxin identified as a known carcinogen—formaldehyde—is an ingredient in many vaccines.”22 23 24 25 A total of 26 vaccines licensed in the U.S. list formaldehyde as an ingredient.”26 Many package inserts published by pharmaceutical companies state that vaccines have not been evaluated for “carcinogenic potential.”27
References:
are malignant—meaning that they can invade and spread to different parts of the body, forming solid tumors (masses of tissue) that can damage organs and tissue.1 2 3 4 5
The 13 most common forms of cancers in the United States are breast cancer, followed by lung, prostrate, colorectal, skin, bladder, lymphatic, kidney, uterine, blood, pancreatic, thyroid and liver cancers.6 In fact, cancer is the second leading cause of death in the U.S.7
A study by the American Cancer Society (ACS) published on Jan. 8, 2019 estimates there will be 1,762,450 new cases of cancer in the U.S. this year and 606,880 deaths caused by cancer, or nearly 1,700 deaths per day.8 9 The number of new cancer cases in the U.S. has been steadily increasing during the past decade. There were about 1.5 million cases in 2010, and the Centers for Disease Control and Prevention (CDC) projects the rate will reach 1.9 million by 2020.10
According to the National Cancer Institute (NCI), the number of new cancer cases of cancer in the U.S. is 439.2 per 100,000 men and women annually. About 38.4 percent of men and women in the U.S. will be diagnosed with cancer “at some point during their lifetimes.”11
The NCI estimates that the national expenditures for cancer care in the U.S. in 2017 were $147 billion, compared to $137.4 billion in 2010. It believes these costs are “likely to increase as the population ages and cancer prevalence increases.”11 12 In fact, it projects that U.S. expenditures for cancer care will reach $174 billion by 2020.13
The ACS estimates that new cancer cases in the U.S. will increase by as much as 50 percent by 2030. This means that, within the next decade, approximately 1 in 2 Americans are expected to be diagnosed with cancer.14 15
Because of this growing and alarming epidemic, there has been a kind of quest by the vaccine manufacturing industry to produce a “universal cancer vaccine” that would treat and help cure cancer by teaching the immune system to attack cancer cells. Even Google has joined the quest by investing millions of dollars in venture capital to help finance start-up biotech companies doing research on a cancer vaccine.16 17
There have been some breakthroughs in recent years on the development of an effective therapeutic cancer vaccine but, thus far, this “holy grail” of the vaccine industry remains elusive.18 19 20
Scientists maintain that human exposure to environmental toxins can cause damage to DNA that alters the way our cells function and leads to cancer.21
Ironically, one toxin identified as a known carcinogen—formaldehyde—is an ingredient in many vaccines.”22 23 24 25 A total of 26 vaccines licensed in the U.S. list formaldehyde as an ingredient.”26 Many package inserts published by pharmaceutical companies state that vaccines have not been evaluated for “carcinogenic potential.”27
References:
No comments:
Post a Comment